Randox are pleased to announce our upcoming webinar to highlight the importance of third party QC for COVID-19 detection in Molecular testing.
Throughout the webinar, key speaker Dr Dwaine Vance will discuss the importance of whole pathogen third party molecular IQC controls.
This discussion will provide tangible examples on how to successfully incorporate the use of a variety of different Qnostics controls into Laboratories testing for SARS-CoV-2. For example, to test for the dynamic range of a molecular assay using Analytical Q Panels, to test the comparable of Methods vs Robotic systems using Molecular Q Panels and to undertake equipment validations and staff training using medium Q Controls.
Download Webinar Materials Below
Dwaine R. Vance BSc (Hons), DIS, PhD
Upon completion of his PhD degree investigating the ‘Genetic predisposition of autoimmune renal disease’, Dr Vance has played an integral part in the development of multiplex PCR syndromic tests within the Randox Molecular R&D department, as well as working as a Molecular Product Specialist developing international business by promoting the importance of appropriate Molecular EQA and Molecular third party IQCs.
Most recently, during the global COVID-19 pandemic, Dwaine has been instrumental in the establishment of a COVID-19 PCR testing laboratory at Randox RCLS Laboratories as part of the UK COVID-19 National Testing Programme.